Fewer hospitalizations for bleeding in digestive system
New data shows that some sarcoma patients are benefiting from treatment with REOLYSIN, developed from a harmless virus called the reovirus that most people are exposed to at some point in their lives. Dr. Monica Mita of the Institute of Drug Development (IDD), the Cancer Therapy and Research Center at the University of Texas Health
Full Post: REOLYSIN shown to benefit some sarcoma patients
Improved treatments for acid reflux disease, ulcers, arthritis and other conditions helped reduce hospital admission rates for internal bleeding in the upper gastrointestinal tract by 14 percent from 1998 to 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The upper gastrointestinal, or “G.I.” tract extends from the mouth to the duodenum, part of the small intestine. Bleeding in this area can be caused by ulcers, taking aspirin and other pain medicines, and alcoholism.
AHRQ’s analysis showed:
- The hospitalization rate for upper G.I. bleeding declined from 96 cases per 100,000 people in 1998 (259,299 total cases) to 82 cases per 100,000 people in 2006 (246,297 cases). Potential reasons for the decline include increased use of medications that reduce gastric acid such as proton pump inhibitors; antibiotic treatment of gastric ulcers caused by the H pylori bacteria; and increased use of the newer COX-2 inhibitor medicines for arthritis or other pain.
- In 2006, hospitalizations for upper G.I. bleeding covered a wide age range — 47 percent of admissions for patients 65 to 84; 25 percent for patients 45 to 64; 18 percent for patients older than 85; 10 percent for patients under 45.
- The number of hospital patients who died from upper G.I. bleeding fell from 20,013 in 1998 to 16,344 in 2006.
This AHRQ News and Numbers is based on Hospitalizations for Gastrointestinal Bleeding in 1998 and 2006 (http://www.hcup-us.ahrq.gov/reports/statbriefs/sb65.pdf) which also has findings for lower G.I. bleeding. The report uses statistics from the 2006 Nationwide Inpatient Sample, a database of hospital inpatient stays that is nationally representative of inpatient stays in all short-term, non-Federal hospitals. The data are drawn from hospitals that comprise 90 percent of all discharges in the United States and include all patients, regardless of insurance type, as well as the uninsured.
According to the latest figures from the Agency for Healthcare Research and Quality (AHRQ) in the United States, one in five hospital admissions are for patients with mental disorders. The AHRQ report says in 2006 about 1.4 million hospitalizations involved patients who were admitted for a mental illness, while another 7.1 million patients had a
Full Post: One in five U.S. hospital admissions are for patients with mental disorders
Hospital admissions for lung cancer remained relatively stable - at roughly 150,000 a year between 1995 and 2006 - despite a steady decline in the number of Americans diagnosed with the disease, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Admissions have remained constant, in part, because lung
Full Post: Hospital admissions for lung cancer stable
Women are more likely than men to be hospitalized for chest pain for which doctors cannot find a cause, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In 2006, there were 477,000 admissions of women to U.S. community hospitals for unspecified chest pain compared with 379,000 admissions for
Full Post: Women more likely than men to be hospitalized for chest pain
Horizon Therapeutics, Inc. has announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the incidence of non-steroidal anti-inflammatory drug (NSAID)-induced upper gastrointestinal (gastric and/or duodenal) ulcers in patients
Full Post: Horizon Therapeutics announces HZT-501 trials meet primary endpoints
About 10.9 million Americans under age 65 purchased individual health insurance policies at some point in 2006, but only 7 million were covered by these policies for the full year, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The 3.9 million individuals who had individual health insurance policies
Full Post: 10.9 million Americans under age 65 have individual health insurance